Innovative Cellular Therapeutics Holdings Ltd
CIK 2095697 · last filed 2026-07-27
Innovative Cellular Therapeutics Holdings Ltd is a corporate insider who has filed 6 SEC Form 4 insider transactions across 1 company since 2026. The most recent filing, for LYEL, was dated Jul 27, 2026. Across all open-market trades the lifetime net is −$274, making them a net seller over the disclosed history. Current disclosed insider exposure totals $37.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$37.60M
1
6
-$274
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LYEL | 10%+ Owner | 2,774,980 | $13.55 | $37.60M | -$274 | 6 | 2026-07-27 |
Recent Filings
6 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-27 | LYEL | Other (J) | −44,000 | $0 | EDGAR |
| 2026-07-27 | LYEL | Other (J) | −38,500 | $0 | EDGAR |
| 2026-07-20 | LYEL | Sell (S) | −10 | -$137 | EDGAR |
| 2026-07-17 | LYEL | Sell (S) | −10 | -$137 | EDGAR |
| 2026-07-01 | LYEL | Other (J) | −76,000 | $0 | EDGAR |
| 2026-06-18 | LYEL | Other (J) | −66,500 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.